Athira Pharma Announces Publication of Phase 1 Results for Fosgonimeton (ATH-1017) in The Journal of Alzheimer’s Disease
Fosgonimeton demonstrated a statistically significant improvement of Event-Related Potential (ERP) P300 latency as compared with…
Keeping the Business Running While IT Recovers: A Practical Continuity Guide
Helport AI Advances Transition to Autonomous AI Labor in Southeast Asian Fintech Market